Interstitial lung disease in a patient with anti-eIF2B antibodies-positive systemic sclerosis: A case report and literature review
We report the case of a 76-year-old male patient with systemic sclerosis positive for anti-eukaryotic initiation factor 2B (eIF2B) antibodies. He presented to our hospital with dyspnea on exertion and, following a comprehensive physical examination, was diagnosed with interstitial lung disease assoc...
Saved in:
| Main Authors: | Naoya Aoshiba, Kazutoshi Toriyama, Shohei Yamashita, Nao Shioiri, Yuko Iwata, Tomonori Uruma, Shinji Abe, Kenji Tsushima |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-01-01
|
| Series: | Respiratory Medicine Case Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2213007124001643 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Newer insights into the management of interstitial lung disease in systemic sclerosis
by: Robert L Mango, et al.
Published: (2017-01-01) -
An exploratory analysis of differences in serum protein expression by sex in patients with systemic sclerosis associated interstitial lung disease
by: Giuliana Cerro-Chiang, et al.
Published: (2025-01-01) -
Quantitative 18F-FDG PET-CT can assess presence and extent of interstitial lung disease in early severe diffuse cutaneous systemic sclerosis
by: Bo Broens, et al.
Published: (2024-12-01) -
Automated AI-based image analysis for quantification and prediction of interstitial lung disease in systemic sclerosis patients
by: Julien Guiot, et al.
Published: (2025-01-01) -
Serum vascular endothelial growth factor levels as a marker of skin thickening, digital ischemia, and interstitial lung disease in systemic sclerosis
by: Chinnadurai Saranya, et al.
Published: (2018-01-01)